Evidence map›Paper›PMID 39671122›Full record

Observational studyClinical rheumatology2025

Relationships between patient and physician global assessments in anti-neutrophil cytoplasmic antibody-associated vasculitis.

Ajinkya Bhonsle, Timothy Coughlan, Rachel Graven, Paula Bussa, Michael Gingold, Kevan R Polkinghorne, Jessica Ryan, A Richard Kitching

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Clinical rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ajinkya BhonsleDepartment of Nephrology, Monash Medical Centre, Monash Health, Clayton, Victoria, Australia.ORCID http://orcid.org/0009-0006-0961-4254
Timothy CoughlanDepartment of Nephrology, Monash Medical Centre, Monash Health, Clayton, Victoria, Australia.
Rachel GravenMonash School of Medicine, Monash University, Clayton, Victoria, Australia.
Paula BussaDepartment of Nephrology, Monash Medical Centre, Monash Health, Clayton, Victoria, Australia.
Michael GingoldDepartment of Rheumatology, Royal Hobart Hospital, Hobart, Australia.
Kevan R PolkinghorneDepartment of Nephrology, Monash Medical Centre, Monash Health, Clayton, Victoria, Australia.
Jessica RyanDepartment of Nephrology, Monash Medical Centre, Monash Health, Clayton, Victoria, Australia.
A Richard KitchingDepartment of Nephrology, Monash Medical Centre, Monash Health, Clayton, Victoria, Australia. richard.kitching@monash.edu.ORCID http://orcid.org/0000-0002-2713-2391

Funding

National Health and Medical Research Council 2008921
6 · The paper itself

Abstract

INTRODUCTION/

objectivesPatients with anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) experience reduced health-related quality of life (HRQoL). Global assessment tools use visual analogue scales to provide patients' and physicians' views on disease activity or the patient's overall health and well-being. The aim of this study was to examine the relationships between patient and physician global assessments (PtGA and PhGa) as they relate to overall health in people with AAV.

methodsPatients with AAV attending a tertiary vasculitis clinic participated in this prospective observational study. The primary outcome measured was PtGA and PhGA scores, with higher scores representing better health. SF-36 assessed HRQoL. Discordant scores were defined as an absolute difference of ≥ 20 between PhGA and PtGA.

resultsNinety-seven patients (mean age 58 years, 46% male) participated. Most were taking immunosuppressive therapy (88%) and had kidney involvement (79%). The mean PhGa and PtGA were similar (mean difference - 2.6, [CI] 0.5, 4.7). Physicians' global assessments were lower in the 43 (44%) patients with active disease, with a trend towards a lower PtGA in this group. Patients' global assessments were ≥ 20 points higher than PhGAs in 16 patients and ≥ 20 points lower in 10 patients. Negatively discordant patients (PtGA < PhGA) were older and less likely to have active disease than positively discordant patients.

conclusionsPhysicians did not systematically overestimate patients' global health when using the global assessment tool. Discordance rates were 26%, within which, physicians were more likely to assess the patient's health lower than patients themselves. Key Points • There remains an unmet need for patient-reported outcomes assessing quality of life in AAV and other diseases. • The global assessment tool correlates with SF-36 which is commonly used as a tool for assessing quality of life. • Physicians do not tend to overestimate patient's global health both overall and within the discordant sub-group. • Assessing PtGA/PhGA discordance could identify unmet priorities for patients and improve shared physician-patient decision-making.

Indexed as

Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisPhysiciansQuality of LifeAdultAgedFemaleHumansMaleMiddle AgedProspective StudiesSeverity of Illness IndexANCA-associated vasculitisDiscordanceGlobal assessmentPatient-reported outcomesQuality of life

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.